Try our Advanced Search for more refined results
BEHESHTI v. KIM et al
Case Number:
2:20-cv-01962
Court:
Nature of Suit:
Other Statutes: Securities/Commodities
Multi Party Litigation:
Derivative Litigation
Judge:
Firms
Companies
Sectors & Industries:
-
June 15, 2023
Inovio Investors Get Derivative Deal OK'd Over Vaccine Claims
Investors in biotechnology firm Inovio Pharmaceuticals Inc. have received an initial green light from a Philadelphia federal judge for their agreement to settle their derivative action against the company's brass over alleged misrepresentations about the company's efforts to produce a vaccine for COVID-19 in a matter of hours.
-
April 19, 2023
Inovio Investors Want 1st OK For COVID-19 Derivative Deal
Several Inovio Pharmaceuticals investors asked a Pennsylvania federal judge on Wednesday to give the first OK to a settlement reached with the company to resolve allegations that Inovio's board of directors lied about the successful development of a COVID-19 vaccine in just three hours.
-
May 29, 2020
COVID-19 Securities Catch-Up: The 8 Biggest Investor Actions
At least 50 federal securities cases with references to COVID-19 have been filed in the past three months, including merger challenges, regulatory enforcement actions and sprawling investor suits, according to a Law360 review of filings. As the pandemic pushes into the summer, Law360 is taking a look at eight major investor actions that were brought in connection with the novel coronavirus since March.
-
April 21, 2020
Inovio Execs Hit With Suit On Heels Of COVID-19 Class Action
An investor hit Inovio Pharmaceuticals Inc. executives with a derivative action on behalf of the company in Pennsylvania federal court Monday, accusing the board of directors of lying about the successful development of a COVID-19 vaccine in just three hours.